Moreover, tumour immunity, such as the inflammatory response, IL6/JAK/STAT3 signalling and IL2/STAT5 signalling, was prominently enriched in parental HCC cells (Figure 2A). This evidence concerns the gene IL2 and hepatocellular carcinoma.